The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The cell and gene therapy isolator integrates cell culture-related functional components such as centrifuges and CO2 incubators, and completes cell culture-related operations in a closed and sterile environment to meet GMP production requirements for cell products.
Highlights
The global Cell and Gene Therapy Isolator market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Cell and Gene Therapy Isolator is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Cell and Gene Therapy Isolator is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Cell and Gene Therapy Isolator include Skan Holding, Netsteril, Comecer, Esco Pharma, Extract Technology, Tema Sinergie, Optima Pharma, Bioquell and BioSpherix, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Cell and Gene Therapy Isolator in Medicine is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Mobile, which accounted for % of the global market of Cell and Gene Therapy Isolator in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Isolator, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Isolator.
The Cell and Gene Therapy Isolator market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Cell and Gene Therapy Isolator market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cell and Gene Therapy Isolator manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Some of the prominent players reviewed in the research report include:
- Skan Holding
- Netsteril
- Comecer
- Esco Pharma
- Extract Technology
- Tema Sinergie
- Optima Pharma
- Bioquell
- BioSpherix
- Germfree
- Lonza
- Sony
- BioAir
- Ecolab
- ZheJiang Tailin Bioengineering
- JCE Biotechnology
- Euroclone
Product Type Insights
Global markets are presented by Cell and Gene Therapy Isolator type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Cell and Gene Therapy Isolator are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Cell and Gene Therapy Isolator segment by Type
- Mobile
- Floor-standing
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Cell and Gene Therapy Isolator market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Cell and Gene Therapy Isolator market.
Cell and Gene Therapy Isolator segment by Application
- Medicine
- Laboratory
- Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina, Colombia)
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Cell and Gene Therapy Isolator market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
- This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy Isolator market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
- This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy Isolator and provides them with information on key market drivers, restraints, challenges, and opportunities.
- This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
- This report stays updated with novel technology integration, features, and the latest developments in the market
- This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Cell and Gene Therapy Isolator industry.
- This report helps stakeholders to gain insights into which regions to target globally
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy Isolator.
- This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cell and Gene Therapy Isolator manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cell and Gene Therapy Isolator in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Index
1 Cell and Gene Therapy Isolator Market Overview
1.1 Product Overview and Scope of Cell and Gene Therapy Isolator
1.2 Cell and Gene Therapy Isolator Segment by Type
1.2.1 Global Cell and Gene Therapy Isolator Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Mobile
1.2.3 Floor-standing
1.3 Cell and Gene Therapy Isolator Segment by Application
1.3.1 Global Cell and Gene Therapy Isolator Sales Comparison by Application: (2022-2028)
1.3.2 Medicine
1.3.3 Laboratory
1.3.4 Others
1.4 Global Cell and Gene Therapy Isolator Market Size Estimates and Forecasts
1.4.1 Global Cell and Gene Therapy Isolator Revenue 2017-2028
1.4.2 Global Cell and Gene Therapy Isolator Sales 2017-2028
1.4.3 Cell and Gene Therapy Isolator Market Size by Region: 2017 Versus 2021 Versus 2028
2 Cell and Gene Therapy Isolator Market Competition by Manufacturers
2.1 Global Cell and Gene Therapy Isolator Sales Market Share by Manufacturers (2017-2022)
2.2 Global Cell and Gene Therapy Isolator Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Cell and Gene Therapy Isolator Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Cell and Gene Therapy Isolator Manufacturing Sites, Area Served, Product Type
2.5 Cell and Gene Therapy Isolator Market Competitive Situation and Trends
2.5.1 Cell and Gene Therapy Isolator Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cell and Gene Therapy Isolator Players Market Share by Revenue
2.5.3 Global Cell and Gene Therapy Isolator Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cell and Gene Therapy Isolator Retrospective Market Scenario by Region
3.1 Global Cell and Gene Therapy Isolator Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Cell and Gene Therapy Isolator Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Cell and Gene Therapy Isolator Market Facts & Figures by Country
3.3.1 North America Cell and Gene Therapy Isolator Sales by Country
3.3.2 North America Cell and Gene Therapy Isolator Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Cell and Gene Therapy Isolator Market Facts & Figures by Country
3.4.1 Europe Cell and Gene Therapy Isolator Sales by Country
3.4.2 Europe Cell and Gene Therapy Isolator Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cell and Gene Therapy Isolator Market Facts & Figures by Region
3.5.1 Asia Pacific Cell and Gene Therapy Isolator Sales by Region
3.5.2 Asia Pacific Cell and Gene Therapy Isolator Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Cell and Gene Therapy Isolator Market Facts & Figures by Country
3.6.1 Latin America Cell and Gene Therapy Isolator Sales by Country
3.6.2 Latin America Cell and Gene Therapy Isolator Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cell and Gene Therapy Isolator Market Facts & Figures by Country
3.7.1 Middle East and Africa Cell and Gene Therapy Isolator Sales by Country
3.7.2 Middle East and Africa Cell and Gene Therapy Isolator Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Cell and Gene Therapy Isolator Historic Market Analysis by Type
4.1 Global Cell and Gene Therapy Isolator Sales Market Share by Type (2017-2022)
4.2 Global Cell and Gene Therapy Isolator Revenue Market Share by Type (2017-2022)
4.3 Global Cell and Gene Therapy Isolator Price by Type (2017-2022)
5 Global Cell and Gene Therapy Isolator Historic Market Analysis by Application
5.1 Global Cell and Gene Therapy Isolator Sales Market Share by Application (2017-2022)
5.2 Global Cell and Gene Therapy Isolator Revenue Market Share by Application (2017-2022)
5.3 Global Cell and Gene Therapy Isolator Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Skan Holding
6.1.1 Skan Holding Corporation Information
6.1.2 Skan Holding Description and Business Overview
6.1.3 Skan Holding Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Skan Holding Cell and Gene Therapy Isolator Product Portfolio
6.1.5 Skan Holding Recent Developments/Updates
6.2 Netsteril
6.2.1 Netsteril Corporation Information
6.2.2 Netsteril Description and Business Overview
6.2.3 Netsteril Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Netsteril Cell and Gene Therapy Isolator Product Portfolio
6.2.5 Netsteril Recent Developments/Updates
6.3 Comecer
6.3.1 Comecer Corporation Information
6.3.2 Comecer Description and Business Overview
6.3.3 Comecer Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Comecer Cell and Gene Therapy Isolator Product Portfolio
6.3.5 Comecer Recent Developments/Updates
6.4 Esco Pharma
6.4.1 Esco Pharma Corporation Information
6.4.2 Esco Pharma Description and Business Overview
6.4.3 Esco Pharma Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Esco Pharma Cell and Gene Therapy Isolator Product Portfolio
6.4.5 Esco Pharma Recent Developments/Updates
6.5 Extract Technology
6.5.1 Extract Technology Corporation Information
6.5.2 Extract Technology Description and Business Overview
6.5.3 Extract Technology Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Extract Technology Cell and Gene Therapy Isolator Product Portfolio
6.5.5 Extract Technology Recent Developments/Updates
6.6 Tema Sinergie
6.6.1 Tema Sinergie Corporation Information
6.6.2 Tema Sinergie Description and Business Overview
6.6.3 Tema Sinergie Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Tema Sinergie Cell and Gene Therapy Isolator Product Portfolio
6.6.5 Tema Sinergie Recent Developments/Updates
6.7 Optima Pharma
6.6.1 Optima Pharma Corporation Information
6.6.2 Optima Pharma Description and Business Overview
6.6.3 Optima Pharma Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Optima Pharma Cell and Gene Therapy Isolator Product Portfolio
6.7.5 Optima Pharma Recent Developments/Updates
6.8 Bioquell
6.8.1 Bioquell Corporation Information
6.8.2 Bioquell Description and Business Overview
6.8.3 Bioquell Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Bioquell Cell and Gene Therapy Isolator Product Portfolio
6.8.5 Bioquell Recent Developments/Updates
6.9 BioSpherix
6.9.1 BioSpherix Corporation Information
6.9.2 BioSpherix Description and Business Overview
6.9.3 BioSpherix Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.9.4 BioSpherix Cell and Gene Therapy Isolator Product Portfolio
6.9.5 BioSpherix Recent Developments/Updates
6.10 Germfree
6.10.1 Germfree Corporation Information
6.10.2 Germfree Description and Business Overview
6.10.3 Germfree Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Germfree Cell and Gene Therapy Isolator Product Portfolio
6.10.5 Germfree Recent Developments/Updates
6.11 Lonza
6.11.1 Lonza Corporation Information
6.11.2 Lonza Cell and Gene Therapy Isolator Description and Business Overview
6.11.3 Lonza Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Lonza Cell and Gene Therapy Isolator Product Portfolio
6.11.5 Lonza Recent Developments/Updates
6.12 Sony
6.12.1 Sony Corporation Information
6.12.2 Sony Cell and Gene Therapy Isolator Description and Business Overview
6.12.3 Sony Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Sony Cell and Gene Therapy Isolator Product Portfolio
6.12.5 Sony Recent Developments/Updates
6.13 BioAir
6.13.1 BioAir Corporation Information
6.13.2 BioAir Cell and Gene Therapy Isolator Description and Business Overview
6.13.3 BioAir Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.13.4 BioAir Cell and Gene Therapy Isolator Product Portfolio
6.13.5 BioAir Recent Developments/Updates
6.14 Ecolab
6.14.1 Ecolab Corporation Information
6.14.2 Ecolab Cell and Gene Therapy Isolator Description and Business Overview
6.14.3 Ecolab Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Ecolab Cell and Gene Therapy Isolator Product Portfolio
6.14.5 Ecolab Recent Developments/Updates
6.15 ZheJiang Tailin Bioengineering
6.15.1 ZheJiang Tailin Bioengineering Corporation Information
6.15.2 ZheJiang Tailin Bioengineering Cell and Gene Therapy Isolator Description and Business Overview
6.15.3 ZheJiang Tailin Bioengineering Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.15.4 ZheJiang Tailin Bioengineering Cell and Gene Therapy Isolator Product Portfolio
6.15.5 ZheJiang Tailin Bioengineering Recent Developments/Updates
6.16 JCE Biotechnology
6.16.1 JCE Biotechnology Corporation Information
6.16.2 JCE Biotechnology Cell and Gene Therapy Isolator Description and Business Overview
6.16.3 JCE Biotechnology Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.16.4 JCE Biotechnology Cell and Gene Therapy Isolator Product Portfolio
6.16.5 JCE Biotechnology Recent Developments/Updates
6.17 Euroclone
6.17.1 Euroclone Corporation Information
6.17.2 Euroclone Cell and Gene Therapy Isolator Description and Business Overview
6.17.3 Euroclone Cell and Gene Therapy Isolator Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Euroclone Cell and Gene Therapy Isolator Product Portfolio
6.17.5 Euroclone Recent Developments/Updates
7 Cell and Gene Therapy Isolator Manufacturing Cost Analysis
7.1 Cell and Gene Therapy Isolator Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cell and Gene Therapy Isolator
7.4 Cell and Gene Therapy Isolator Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cell and Gene Therapy Isolator Distributors List
8.3 Cell and Gene Therapy Isolator Customers
9 Cell and Gene Therapy Isolator Market Dynamics
9.1 Cell and Gene Therapy Isolator Industry Trends
9.2 Cell and Gene Therapy Isolator Market Drivers
9.3 Cell and Gene Therapy Isolator Market Challenges
9.4 Cell and Gene Therapy Isolator Market Restraints
10 Global Market Forecast
10.1 Cell and Gene Therapy Isolator Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cell and Gene Therapy Isolator by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Cell and Gene Therapy Isolator by Type (2023-2028)
10.2 Cell and Gene Therapy Isolator Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cell and Gene Therapy Isolator by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Cell and Gene Therapy Isolator by Application (2023-2028)
10.3 Cell and Gene Therapy Isolator Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cell and Gene Therapy Isolator by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Cell and Gene Therapy Isolator by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Cell and Gene Therapy Isolator Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
Table 2. Global Cell and Gene Therapy Isolator Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
Table 3. Global Cell and Gene Therapy Isolator Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Cell and Gene Therapy Isolator Market Competitive Situation by Manufacturers in 2021
Table 5. Global Cell and Gene Therapy Isolator Sales (Units) of Key Manufacturers (2017-2022)
Table 6. Global Cell and Gene Therapy Isolator Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Cell and Gene Therapy Isolator Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Cell and Gene Therapy Isolator Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Cell and Gene Therapy Isolator Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Cell and Gene Therapy Isolator Manufacturing Sites and Area Served
Table 11. Manufacturers Cell and Gene Therapy Isolator Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Cell and Gene Therapy Isolator by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cell and Gene Therapy Isolator as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Cell and Gene Therapy Isolator Sales by Region (2017-2022) & (Units)
Table 16. Global Cell and Gene Therapy Isolator Sales Market Share by Region (2017-2022)
Table 17. Global Cell and Gene Therapy Isolator Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Cell and Gene Therapy Isolator Revenue Market Share by Region (2017-2022)
Table 19. North America Cell and Gene Therapy Isolator Sales by Country (2017-2022) & (Units)
Table 20. North America Cell and Gene Therapy Isolator Sales Market Share by Country (2017-2022)
Table 21. North America Cell and Gene Therapy Isolator Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Cell and Gene Therapy Isolator Revenue Market Share by Country (2017-2022)
Table 23. Europe Cell and Gene Therapy Isolator Sales by Country (2017-2022) & (Units)
Table 24. Europe Cell and Gene Therapy Isolator Sales Market Share by Country (2017-2022)
Table 25. Europe Cell and Gene Therapy Isolator Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Cell and Gene Therapy Isolator Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Cell and Gene Therapy Isolator Sales by Region (2017-2022) & (Units)
Table 28. Asia Pacific Cell and Gene Therapy Isolator Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Cell and Gene Therapy Isolator Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Cell and Gene Therapy Isolator Revenue Market Share by Region (2017-2022)
Table 31. Latin America Cell and Gene Therapy Isolator Sales by Country (2017-2022) & (Units)
Table 32. Latin America Cell and Gene Therapy Isolator Sales Market Share by Country (2017-2022)
Table 33. Latin America Cell and Gene Therapy Isolator Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Cell and Gene Therapy Isolator Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Cell and Gene Therapy Isolator Sales by Country (2017-2022) & (Units)
Table 36. Middle East and Africa Cell and Gene Therapy Isolator Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Cell and Gene Therapy Isolator Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Cell and Gene Therapy Isolator Revenue Market Share by Country (2017-2022)
Table 39. Global Cell and Gene Therapy Isolator Sales by Type (2017-2022) & (Units)
Table 40. Global Cell and Gene Therapy Isolator Sales Market Share by Type (2017-2022)
Table 41. Global Cell and Gene Therapy Isolator Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Cell and Gene Therapy Isolator Revenue Share by Type (2017-2022)
Table 43. Global Cell and Gene Therapy Isolator Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Cell and Gene Therapy Isolator Sales (Units) by Application (2017-2022)
Table 45. Global Cell and Gene Therapy Isolator Sales Market Share by Application (2017-2022)
Table 46. Global Cell and Gene Therapy Isolator Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Cell and Gene Therapy Isolator Revenue Share by Application (2017-2022)
Table 48. Global Cell and Gene Therapy Isolator Price by Application (2017-2022) & (US$/Unit)
Table 49. Skan Holding Corporation Information
Table 50. Skan Holding Description and Business Overview
Table 51. Skan Holding Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Skan Holding Cell and Gene Therapy Isolator Product
Table 53. Skan Holding Recent Developments/Updates
Table 54. Netsteril Corporation Information
Table 55. Netsteril Description and Business Overview
Table 56. Netsteril Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Netsteril Cell and Gene Therapy Isolator Product
Table 58. Netsteril Recent Developments/Updates
Table 59. Comecer Corporation Information
Table 60. Comecer Description and Business Overview
Table 61. Comecer Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Comecer Cell and Gene Therapy Isolator Product
Table 63. Comecer Recent Developments/Updates
Table 64. Esco Pharma Corporation Information
Table 65. Esco Pharma Description and Business Overview
Table 66. Esco Pharma Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Esco Pharma Cell and Gene Therapy Isolator Product
Table 68. Esco Pharma Recent Developments/Updates
Table 69. Extract Technology Corporation Information
Table 70. Extract Technology Description and Business Overview
Table 71. Extract Technology Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Extract Technology Cell and Gene Therapy Isolator Product
Table 73. Extract Technology Recent Developments/Updates
Table 74. Tema Sinergie Corporation Information
Table 75. Tema Sinergie Description and Business Overview
Table 76. Tema Sinergie Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Tema Sinergie Cell and Gene Therapy Isolator Product
Table 78. Tema Sinergie Recent Developments/Updates
Table 79. Optima Pharma Corporation Information
Table 80. Optima Pharma Description and Business Overview
Table 81. Optima Pharma Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Optima Pharma Cell and Gene Therapy Isolator Product
Table 83. Optima Pharma Recent Developments/Updates
Table 84. Bioquell Corporation Information
Table 85. Bioquell Description and Business Overview
Table 86. Bioquell Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Bioquell Cell and Gene Therapy Isolator Product
Table 88. Bioquell Recent Developments/Updates
Table 89. BioSpherix Corporation Information
Table 90. BioSpherix Description and Business Overview
Table 91. BioSpherix Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. BioSpherix Cell and Gene Therapy Isolator Product
Table 93. BioSpherix Recent Developments/Updates
Table 94. Germfree Corporation Information
Table 95. Germfree Description and Business Overview
Table 96. Germfree Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Germfree Cell and Gene Therapy Isolator Product
Table 98. Germfree Recent Developments/Updates
Table 99. Lonza Corporation Information
Table 100. Lonza Description and Business Overview
Table 101. Lonza Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Lonza Cell and Gene Therapy Isolator Product
Table 103. Lonza Recent Developments/Updates
Table 104. Sony Corporation Information
Table 105. Sony Description and Business Overview
Table 106. Sony Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Sony Cell and Gene Therapy Isolator Product
Table 108. Sony Recent Developments/Updates
Table 109. BioAir Corporation Information
Table 110. BioAir Description and Business Overview
Table 111. BioAir Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. BioAir Cell and Gene Therapy Isolator Product
Table 113. BioAir Recent Developments/Updates
Table 114. Ecolab Corporation Information
Table 115. Ecolab Description and Business Overview
Table 116. Ecolab Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Ecolab Cell and Gene Therapy Isolator Product
Table 118. Ecolab Recent Developments/Updates
Table 119. ZheJiang Tailin Bioengineering Corporation Information
Table 120. ZheJiang Tailin Bioengineering Description and Business Overview
Table 121. ZheJiang Tailin Bioengineering Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. ZheJiang Tailin Bioengineering Cell and Gene Therapy Isolator Product
Table 123. ZheJiang Tailin Bioengineering Recent Developments/Updates
Table 124. JCE Biotechnology Corporation Information
Table 125. JCE Biotechnology Description and Business Overview
Table 126. JCE Biotechnology Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. JCE Biotechnology Cell and Gene Therapy Isolator Product
Table 128. JCE Biotechnology Recent Developments/Updates
Table 129. Euroclone Corporation Information
Table 130. Euroclone Description and Business Overview
Table 131. Euroclone Cell and Gene Therapy Isolator Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Euroclone Cell and Gene Therapy Isolator Product
Table 133. Euroclone Recent Developments/Updates
Table 134. Production Base and Market Concentration Rate of Raw Material
Table 135. Key Suppliers of Raw Materials
Table 136. Cell and Gene Therapy Isolator Distributors List
Table 137. Cell and Gene Therapy Isolator Customers List
Table 138. Cell and Gene Therapy Isolator Market Trends
Table 139. Cell and Gene Therapy Isolator Market Drivers
Table 140. Cell and Gene Therapy Isolator Market Challenges
Table 141. Cell and Gene Therapy Isolator Market Restraints
Table 142. Global Cell and Gene Therapy Isolator Sales Forecast by Type (2023-2028) & (Units)
Table 143. Global Cell and Gene Therapy Isolator Sales Market Share Forecast by Type (2023-2028)
Table 144. Global Cell and Gene Therapy Isolator Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 145. Global Cell and Gene Therapy Isolator Revenue Market Share Forecast by Type (2023-2028)
Table 146. Global Cell and Gene Therapy Isolator Sales Forecast by Application (2023-2028) & (Units)
Table 147. Global Cell and Gene Therapy Isolator Sales Market Share Forecast by Application (2023-2028)
Table 148. Global Cell and Gene Therapy Isolator Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 149. Global Cell and Gene Therapy Isolator Revenue Market Share Forecast by Application (2023-2028)
Table 150. Global Cell and Gene Therapy Isolator Sales Forecast by Region (2023-2028) & (Units)
Table 151. Global Cell and Gene Therapy Isolator Sales Market Share Forecast by Region (2023-2028)
Table 152. Global Cell and Gene Therapy Isolator Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 153. Global Cell and Gene Therapy Isolator Revenue Market Share Forecast by Region (2023-2028)
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cell and Gene Therapy Isolator
Figure 2. Global Cell and Gene Therapy Isolator Market Share by Type in 2021 & 2028
Figure 3. Mobile Product Picture
Figure 4. Floor-standing Product Picture
Figure 5. Global Cell and Gene Therapy Isolator Market Share by Application in 2021 & 2028
Figure 6. Medicine
Figure 7. Laboratory
Figure 8. Others
Figure 9. Global Cell and Gene Therapy Isolator Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Cell and Gene Therapy Isolator Market Size (2017-2028) & (US$ Million)
Figure 11. Global Cell and Gene Therapy Isolator Sales (2017-2028) & (Units)
Figure 12. Cell and Gene Therapy Isolator Sales Share by Manufacturers in 2021
Figure 13. Global Cell and Gene Therapy Isolator Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Cell and Gene Therapy Isolator Players: Market Share by Revenue in 2021
Figure 15. Cell and Gene Therapy Isolator Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Cell and Gene Therapy Isolator Sales Market Share by Region (2017-2022)
Figure 17. Global Cell and Gene Therapy Isolator Sales Market Share by Region in 2021
Figure 18. Global Cell and Gene Therapy Isolator Revenue Market Share by Region (2017-2022)
Figure 19. Global Cell and Gene Therapy Isolator Revenue Market Share by Region in 2021
Figure 20. United States Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Cell and Gene Therapy Isolator Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Cell and Gene Therapy Isolator by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Cell and Gene Therapy Isolator
Figure 44. Manufacturing Process Analysis of Cell and Gene Therapy Isolator
Figure 45. Cell and Gene Therapy Isolator Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
